{
  "meta": {
    "title": "46_Carcinoma_Endometrium",
    "url": "https://brainandscalpel.vercel.app/46-carcinoma-endometrium-0444afd4.html",
    "scrapedAt": "2025-11-30T12:30:07.721Z"
  },
  "questions": [
    {
      "text": "What is the most common cause of postmenopausal bleeding?",
      "choices": [
        {
          "id": 1,
          "text": "Senile endometrial atrophy"
        },
        {
          "id": 2,
          "text": "Cervical cancer"
        },
        {
          "id": 3,
          "text": "Endometrial cancer"
        },
        {
          "id": 4,
          "text": "Atypical endometrial hyperplasia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>most common</strong> cause of postmenopausal bleeding all over the world is <strong>s</strong><strong>enile endometrial atrophy.</strong></p>\n<p>In a menopausal woman, <strong>hypoestrogenism</strong> causes <strong>atrophy</strong> of the <strong>endometrium</strong> and<strong> vagina</strong>.The <strong>atrophic endometrial</strong> <strong>surfaces</strong> contain little or no fluid to prevent intracavitary friction. This results in <strong>micro-erosions</strong> of the surface epithelium and a subsequent <strong>chronic inflammatory reaction</strong>, making the endometrium prone to light bleeding or spotting.</p>\n<p><strong>Hormone replacement therapy&nbsp;</strong>is the <strong>second most common</strong> cause of&nbsp;post-menopausal bleeding all over the world.&nbsp;</p>\n<p><strong>Cervical cancer</strong>&nbsp;is the most common cause of postmenopausal bleeding in <strong>India</strong>, while <strong>endometrial cancer</strong>&nbsp;is the most common cause of postmenopausal bleeding in <strong>developed countries</strong>.</p>\n<p>Note: Endometrial cancer accounts for only 10 % of cases of post-menopausal bleeding. Still, all postmenopausal women with unexpected uterine bleeding should be evaluated for endometrial carcinoma, since this is a potentially lethal disease.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0270",
      "difficulty": "medium"
    },
    {
      "text": "A 58-year-old, postmenopausal woman presented with bleeding PV. Hysteroscopic biopsy revealed complex endometrial hyperplasia with atypia. What is the risk of progression of this condition to cancer?",
      "choices": [
        {
          "id": 1,
          "text": "3%"
        },
        {
          "id": 2,
          "text": "54%"
        },
        {
          "id": 3,
          "text": "8%"
        },
        {
          "id": 4,
          "text": "29%"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Complex hyperplasia</strong> with <strong>atypia</strong> has a <strong>29%</strong> increased risk of progression to endometrial cancer. It has the <strong>highest risk</strong> of progressing to carcinoma compared to other varieties of endometrial hyperplasia.</p>\n<p>The risk of endometrial hyperplasia progressing to cancer is tabulated below.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type of hyperplasia</strong></td>\n<td><strong>Progression to cancer</strong></td>\n</tr>\n<tr>\n<td>Simple without atypia</td>\n<td>1%</td>\n</tr>\n<tr>\n<td>Complex without atypia</td>\n<td>3%</td>\n</tr>\n<tr>\n<td>Simple with atypia</td>\n<td>8%</td>\n</tr>\n<tr>\n<td>Complex with atypia</td>\n<td>29%</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0266",
      "difficulty": "easy"
    },
    {
      "text": "Which is the most common benign cause of pyometra?",
      "choices": [
        {
          "id": 1,
          "text": "Endometrial hyperplasia"
        },
        {
          "id": 2,
          "text": "Senile endometritis"
        },
        {
          "id": 3,
          "text": "Pelvic inflammatory disease"
        },
        {
          "id": 4,
          "text": "Cervical stenosis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>most common cause</strong> of pyometra is <strong>senile endometritis.</strong></p>\n<p><strong>Pyometra</strong>&nbsp;refers the collection of <strong>pus</strong> in the <strong>uterus</strong>. The most common cancer that causes pyometra is carcinoma cervix followed by carcinoma endometrium.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0271",
      "difficulty": "medium"
    },
    {
      "text": "Which among the following is an ideal treatment for a 55-year-old female with simple hyperplasia of the endometrium with atypia?",
      "choices": [
        {
          "id": 1,
          "text": "Simple hysterectomy"
        },
        {
          "id": 2,
          "text": "Medroxy progesterone acetate"
        },
        {
          "id": 3,
          "text": "Levonorgesterol"
        },
        {
          "id": 4,
          "text": "Radiotherapy"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Simple hysterectomy</strong> is the best treatment in a case of <strong>atypical</strong> endometrial <strong>hyperplasia&nbsp;</strong>in a <strong>peri-menopausal</strong> and<strong> post-menopausal</strong> female.</p>\n<p>Endometrial hyperplasia <strong>with atypia</strong> carries <strong>29% risk</strong> of <strong>developing into</strong> endometrial <strong>carcinoma</strong> and hence, must be <strong>treated</strong> with <strong>total abdominal hysterectomy</strong> (simple hysterectomy ). The&nbsp;presence of any <strong>concomitant endometrial cancer&nbsp;</strong>must be ruled out by doing <strong>fractional curettage</strong>&nbsp;(or dilatation and curettage) <strong>before</strong> doing a <strong>hysterectomy</strong>.</p>\n<p>If a premenopausal woman does not desire to undergo hysterectomy, <strong>progesterone</strong> can be given and the patient is followed up every 3-6 months. If the <strong>atypia</strong> <strong>persists</strong> during the follow-up<strong> hysterectomy</strong> should be performed.</p>\n<p>The table below summarizes the management of patients with endometrial hyperplasia</p><table>\n<tbody>\n<tr>\n<td><strong>Management of Endometrial hyperplasia</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Hyperplasia without atypia</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Pre-menopausal women</td>\n<td>Progesterone therapy</td>\n</tr>\n<tr>\n<td>Postmenopausal women:\n<ul>\n<li>Simple hyperplasia without atypia</li>\n<li>Complex hyperplasia without atypia</li>\n</ul>\n</td>\n<td>\n<p>&nbsp;</p>\n<ul>\n<li>Follow up without therapy</li>\n<li>Progesterone therapy</li>\n</ul>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td><strong>Hyperplasia with atypia</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Pre-menopausal women</td>\n<td>\n<p>If patient wishes to preserve uterus,give High-dose progesterone therapy</p>\n<p>If atypia persists, then perform Total abdominal hysterectomy</p>\n</td>\n</tr>\n<tr>\n<td>Peri-menopausal women</td>\n<td>Total abdominal hysterectomy</td>\n</tr>\n<tr>\n<td>Post-menopausal women</td>\n<td>Total abdominal hysterectomy +BSO (bilateral salphingo-ophorectomy)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0267",
      "difficulty": "easy"
    },
    {
      "text": "What is the minimum endometrial thickness on transvaginal ultrasonography, above which you perform a biopsy in a case of postmenopausal bleeding?",
      "choices": [
        {
          "id": 1,
          "text": "3mm"
        },
        {
          "id": 2,
          "text": "4mm"
        },
        {
          "id": 3,
          "text": "7mm"
        },
        {
          "id": 4,
          "text": "9mm"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>A finding of endometrial thickness <strong>&ge;&nbsp;4 mm </strong>(according to ACOG)<strong>&nbsp;</strong>in a <strong>postmenopausal women</strong>&nbsp;requires further evaluation, such as endometrial biopsy.</p>\n<p>If the endometrial thickness is <strong>&le;4 mm</strong> in a <strong>post menopausal female</strong>, malignancy is rare and hence, can be managed by <strong>tranexamic acid</strong>. If the <strong>bleeding</strong> still <strong>persists</strong>, the patient needs to undergo <strong>fractional curettage and hysteroscopy.</strong></p>\n<p>The algorithm for <strong>next step</strong> for <strong>abnormal uterine bleeding</strong> in different age groups is as follows:</p><table>\n<tbody>\n<tr>\n<td>&nbsp;Age group</td>\n<td>Endometrial thickness on TVS</td>\n<td>Action</td>\n</tr>\n<tr>\n<td>Age &lt;40years</td>\n<td>&nbsp;&gt;12mm</td>\n<td>Endometrial sampling/Endometrial biopsy</td>\n</tr>\n<tr>\n<td>Age&gt;40 years or Age &gt;45 years</td>\n<td>-</td>\n<td>Endometrial sampling/Endometrial biopsy is done irrespective of usg findings</td>\n</tr>\n<tr>\n<td>Post menopausal women</td>\n<td>&ge;4mm</td>\n<td>&nbsp;Endometrial sampling/Endometrial biopsy</td>\n</tr>\n<tr>\n<td>Post menopausal women</td>\n<td>&lt;4mm</td>\n<td>\n<ul>\n<li>Reassurance+tranexamic acid</li>\n<li>If, bleeding still persists then do endometrial biopsy</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/acac31efbf3e49dca75bdc3081987821x1280x2320.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5254",
      "difficulty": "easy"
    },
    {
      "text": "What is the most common histopathological variety of endometrial cancer?",
      "choices": [
        {
          "id": 1,
          "text": "Squamous cell"
        },
        {
          "id": 2,
          "text": "Adenocarcinoma"
        },
        {
          "id": 3,
          "text": "Clear cell"
        },
        {
          "id": 4,
          "text": "Serous"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>most common</strong> variety of endometrial cancer is <strong>adenocarcinoma</strong>.</p>\n<p>The other varieties of endometrial cancer are squamous cell, clear cell, and serous.&nbsp;The <strong>most malignant </strong>varieties are&nbsp;<strong>clear cell </strong>carcinoma and <strong>papillary serous </strong>tumor.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5074",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following predisposes a patient to develop type 2 carcinoma endometrium?",
      "choices": [
        {
          "id": 1,
          "text": "KRAS mutation"
        },
        {
          "id": 2,
          "text": "Premenopausal age group"
        },
        {
          "id": 3,
          "text": "PTEN mutation"
        },
        {
          "id": 4,
          "text": "Atrophic endometrium"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Type 2 carcinoma endometrium</strong> is commonly seen in menopausal women with <strong>atrophic endometrium</strong>.</p>\n<p><strong>Histological classification</strong> of endometrial cancer:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type 1 (Endometrioid)</strong></td>\n<td><strong>Type 2 (Nonendometriod)</strong></td>\n</tr>\n<tr>\n<td>Estrogen dependent</td>\n<td>Estrogen independent</td>\n</tr>\n<tr>\n<td>Occurs in Pre- and Peri-menopausal women</td>\n<td>Occurs in post-menopausal women</td>\n</tr>\n<tr>\n<td>Hyperplasia present</td>\n<td>Hyperplasia absent</td>\n</tr>\n<tr>\n<td>Good prognosis</td>\n<td>Poor prognosis</td>\n</tr>\n<tr>\n<td>Associated with PTEN/KRAS mutation</td>\n<td>Associated with p53 mutation</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note: Type 1 (estrogen-dependent) endometrial CA is the more common type.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5077",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following constitute corpus cancer syndrome?<div class='question-desc-html'><ol>\n<li>Obesity</li>\n<li>Hypertension</li>\n<li>Stroke</li>\n<li>Diabetes mellitus&nbsp;</li>\n<li>Endometrial carcinoma</li>\n<li>Dysgerminoma</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2, 3, 5"
        },
        {
          "id": 2,
          "text": "1, 3, 4, 6"
        },
        {
          "id": 3,
          "text": "1, 2, 4, 5"
        },
        {
          "id": 4,
          "text": "1, 3, 4, 5"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Corpus cancer syndrome</strong> constitutes of:</p>\n<ul>\n<li>Diabetes mellitus</li>\n<li>Obesity</li>\n<li>Hypertension</li>\n<li>Cancer of the body of the&nbsp;uterus.</li>\n</ul>\n<p><strong>Etiology of endometrial carcinoma</strong>:&nbsp;(Mnemonic: Family Has OLD AUNTI)</p>\n<ul>\n<li>Family history</li>\n<li><strong>Hypertension</strong></li>\n<li><strong>Obesity</strong></li>\n<li>Late menopause/Early menarche</li>\n<li><strong>Diabetes</strong></li>\n<li>Atypical endometrial hyperplasia</li>\n<li>Unopposed estrogen/increased estrogen &rarr; Hormone replacement therapy, fibroid, PCOD</li>\n<li>Nulliparous</li>\n<li>Tamoxifen therapy<strong>&nbsp;</strong>(Raloxifene has no genito-urinary action)</li>\n<li>Infertility/irregular menses.</li>\n</ul>\n<p><strong>Protective factors</strong> against endometrial carcinoma include the use of&nbsp;<strong>OCPs</strong>, <strong>smoking,</strong> and <strong>multiparity</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5073",
      "difficulty": "easy"
    },
    {
      "text": "A gynecologist is performing the following procedure in a woman with postmenopausal bleeding. Identify it.",
      "choices": [
        {
          "id": 1,
          "text": "Transvaginal sonography"
        },
        {
          "id": 2,
          "text": "Balloon endometrial ablation"
        },
        {
          "id": 3,
          "text": "Saline infusion sonography"
        },
        {
          "id": 4,
          "text": "Hysterosalpingography"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The image depicts <strong>s</strong><strong>aline infusion sonography </strong>(SIS), also known as&nbsp;<strong>sonohysterography</strong>. It is usually done after a transvaginal ultrasound, to <strong>assess</strong> the detailed <strong>anatomy</strong> of the <strong>uterine cavity.</strong></p>\n<p>In this procedure,&nbsp;a balloon catheter is inserted through the cervix and&nbsp;the<strong> endometrial cavity</strong> is <strong>distended</strong> with 20-40ml of <strong>sterile saline.&nbsp;</strong>The balloon is inflated to block the backflow of the infused sterile saline and <strong>transvaginal ultrasound</strong> is performed to visualize the cavity.&nbsp;</p>\n<p>It is used:</p>\n<ul>\n<li>To determine the endometrial thickness&nbsp;</li>\n<li>To determine the cause in cases of infertility</li>\n<li>To identify Mullerian anomalies&nbsp;</li>\n<li>To visualize endometrial polyps and pedunculated fibroids</li>\n</ul>\n<p>The image given below shows the appearance of the uterus on SIS.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e182e5cd908b483ab4db1f0ffd7cbfd5x625x481.JPEG\" alt=\"Explanation Image\"><p>Option A: Transvaginal ultrasound is the initial evaluation for postmenopausal bleeding.</p>\n<p>Option B: In balloon endometrial ablation, a balloon is inserted into the uterus and inflated with glycine or 5% glucose. It is then heated up, and the endometrium is ablated by the tamponade effect.</p>\n<p>Option D: In hysterosalpingography, contrast dye is inserted into the uterus via a catheter, and the uterine and fallopian tube anatomy is visualized.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/31727b8d761b475aa0c8a9972b9771d3.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0653",
      "difficulty": "medium"
    },
    {
      "text": "A menopausal patient suspected to have endometrial carcinoma is undergoing a transvaginal ultrasound. Which of the following findings would be inconsistent with her diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Endometrial thickness of 7 mm"
        },
        {
          "id": 2,
          "text": "Hyperechoic endometrium"
        },
        {
          "id": 3,
          "text": "Increased vascular resistance"
        },
        {
          "id": 4,
          "text": "Fluid in uterine cavity"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Decreased vascular resistance</strong> with increased tumor vascularity is seen in <strong>carcinoma endometrium</strong>.</p>\n<p><strong>USG findings</strong> in carcinoma endometrium include:</p>\n<ul>\n<li>Endometrial thickness &gt;4 mm in postmenopausal women and &gt;10 mm in perimenopausal women</li>\n<li>Hyperechoic endometrium with irregular outlines</li>\n<li>Increased tumor vascularity with low vascular resistance</li>\n<li>Fluid in uterine cavity</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5080",
      "difficulty": "hard"
    },
    {
      "text": "A 52-year-old​ woman with postmenopausal bleeding has an endometrial thickness of 7 mm on ultrasound. What is the next step in her management?",
      "choices": [
        {
          "id": 1,
          "text": "Follow up USG after 3 months"
        },
        {
          "id": 2,
          "text": "Hysterectomy"
        },
        {
          "id": 3,
          "text": "Endometrial biopsy"
        },
        {
          "id": 4,
          "text": "Progesterone therapy"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The next line of management in a patient with increased endometrial thickness is an&nbsp;<strong>endometrial biopsy</strong>.</p>\n<p>In a <strong>postmenopausal</strong> woman, the normal <strong>endometrium</strong> should not exceed 4 mm in thickness. If it <strong>exceeds 4 mm</strong>, then histopathological examination (<strong>HPE</strong>) of the endometrium is mandatory, <strong>irrespective</strong> of the presence or absence of <strong>symptoms.&nbsp;</strong>In a <strong>perimenopausal</strong> woman, the cutoff for normal <strong>endometrial</strong> thickness is&nbsp;<strong>10mm</strong>.&nbsp;</p>\n<p><strong>Hysteroscopy and biopsy </strong>is <strong>preferred</strong> over other blind curettage methods for HPE. A biopsy is made from suspicious areas after visualization so chances of missing the lesion are reduced.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6979",
      "difficulty": "easy"
    },
    {
      "text": "A 54-year-old woman with postmenopausal bleeding is suspected to have an endometrial lesion. What is the gold standard investigation to confirm her diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Fractional curettage"
        },
        {
          "id": 2,
          "text": "Dilatation and curettage"
        },
        {
          "id": 3,
          "text": "Hysteroscopic biopsy"
        },
        {
          "id": 4,
          "text": "Laparoscopic biopsy"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<div class=\"page\" title=\"Page 89\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Hysteroscopic inspection </strong>and selective <strong>biopsy</strong> is now considered the<strong> gold standard</strong> in the diagnosis of an<strong> endometrial lesion.&nbsp;</strong>It is preferred&nbsp;for the <strong>initial evaluation</strong> of women with bleeding suspicious for malignancy.</p>\n<p>Endometrial sampling can be done by&nbsp;hysteroscopic biopsy. It is more sensitive for&nbsp;focal endometrial lesions.&nbsp;Dilatation and curettage may also aid the sampling of endometrial lesions.</p>\n<div class=\"page\" title=\"Page 735\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 735\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 732\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Ultrasound, CT, and MRI are adjuvant to other investigations.&nbsp;<strong>Diagnostic laparoscopy</strong> will be required to study the nature of the tumor and its spread if ultrasound picks up a <strong>pelvic tumor</strong>.</p>\n<p>The image given below shows the procedure of hysteroscopy.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/eb433d5ed4324c3f9e7634b2ae1f3c14x1280x878.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0924",
      "difficulty": "medium"
    },
    {
      "text": "A 62-year-old woman presents with vaginal bleeding 11 years after she had attained menopause. An endometrial biopsy reveals adenocarcinoma. What is the gold standard method for staging her condition?",
      "choices": [
        {
          "id": 1,
          "text": "MRI"
        },
        {
          "id": 2,
          "text": "Surgery"
        },
        {
          "id": 3,
          "text": "Endometrial biopsy"
        },
        {
          "id": 4,
          "text": "PET-CT"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given scenario depicts <strong>endometrial carcinoma </strong>and the <strong>gold standard</strong> method for <strong>staging</strong> this condition is <strong>surgery.</strong></p>\n<p>According to <span class=\"nowrap\">FIGO/TNM</span>&nbsp;classification system,&nbsp;a&nbsp;<strong>total hysterectomy</strong> with <strong>bilateral salpingo-oophorectomy</strong> and <strong>pelvic and para-aortic lymph node dissection</strong> is the standard staging procedure for endometrial cancer.&nbsp;</p>\n<p>Option A: Contrast-enhanced <strong>magnetic resonance imaging</strong> (MRI) appears to be the best radiographic modality for detecting<strong> myometrial invasion</strong> or <strong>cervical involvement</strong>.</p>\n<p>Option C: <strong>Hysteroscopy </strong>visualizes the entire uterine lining and a <strong>biopsy</strong> is taken from suspicious areas. This is not 100% predictive, as an <strong>early lesion</strong> can be <strong>missed</strong>. Recently, the concern has been raised regarding the&nbsp;spilling of cancer cells into the peritoneal cavity during hysteroscopy.</p>\n<p>Option D: <strong>PET&ndash;CT</strong> reveals metabolic activity in the tissue and is highly sensitive and specific for detecting positive<strong> pelvic and/or para-aortic lymphadenopathy</strong> as well as <strong>distant metastases</strong> in selected high-risk patients with endometrial cancer.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5079",
      "difficulty": "medium"
    },
    {
      "text": "Which lymph nodes are most commonly involved in patients with endometrial carcinoma?",
      "choices": [
        {
          "id": 1,
          "text": "Femoral"
        },
        {
          "id": 2,
          "text": "Inguinal"
        },
        {
          "id": 3,
          "text": "Para-aortic"
        },
        {
          "id": 4,
          "text": "Para-colic"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Pelvic</strong> and <strong>para-aortic</strong> lymph nodes are commonly involved in <strong>endometrial cancer</strong>.</p>\n<p>The spread is through the infundibulopelvic ligament.</p>\n<p>Rarely, inguinal &amp; femoral lymph nodes are involved.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5078",
      "difficulty": "easy"
    },
    {
      "text": "A patient presented with carcinoma endometrium involving >50% myometrium, extending to the vagina but with no involvement of para-aortic and pre aortic nodes. What is the stage of her disease?",
      "choices": [
        {
          "id": 1,
          "text": "III A"
        },
        {
          "id": 2,
          "text": "III B"
        },
        {
          "id": 3,
          "text": "III C1"
        },
        {
          "id": 4,
          "text": "III C2"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Carcinoma endometrium</strong> <strong>involving</strong> the <strong>vagina</strong> but having no lymph node involvement is classified as stage&nbsp;<strong>IIIB</strong>.</p><hr><h3>Related Pearl: Ca.Endometrium staging (Revised FIGO)</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/63d7bd1024964af5a59c406cbaa3fc47x1280x3298.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4a582a55999043d8a33c2034dd59de86x1280x882.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0269",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is indicated for the treatment of a patient with early endometrial cancer?",
      "choices": [
        {
          "id": 1,
          "text": "Hysterectomy, B/L salpingo-oophorectomy, lymph node sampling"
        },
        {
          "id": 2,
          "text": "Hysterectomy, B/L salpingo-oophorectomy, chemoradiation"
        },
        {
          "id": 3,
          "text": "Hysterectomy, radiotherapy"
        },
        {
          "id": 4,
          "text": "Chemoradiation"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Early endometrial cancer</strong> (stages I &amp; II) is primarily <strong>managed surgically</strong>. The surgery performed here is&nbsp;abdominal hysterectomy,&nbsp;B/L salpingo-oophorectomy,&nbsp;omentectomy and pelvic &amp; para-aortic lymph node sampling.</p>\n<p><strong>Postoperative management</strong> of endometrial cancer:</p>\n<p>In <strong>low-risk</strong> endometrial cancer,<strong> no further treatment</strong> is required.</p>\n<p>In intermediate-risk, radiotherapy is done.</p>\n<p>In high risk, chemotherapy + radiotherapy is done.</p><hr><h3>Related Pearl: Management of endometrial cancer</h3><p>Surgery is done for staging of the cancer. The surgery done for this purpose is abdominal hysterectomy, bilateral salpingo-oophorectomy, omentectomy, and pelvic as well as para-aortic lymph node sampling.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Stage</strong></td>\n<td><strong>Treatment</strong></td>\n</tr>\n<tr>\n<td><strong>IA noninvasive&nbsp;</strong></td>\n<td>\n<ul>\n<li>Surgery alone</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>IA</strong></td>\n<td>\n<ul>\n<li>Surgery</li>\n<li>Post-op radiotherapy</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>IB</strong></td>\n<td>\n<ul>\n<li>Surgery</li>\n<li>Post-op pelvic radiotherapy 4000-5000 cGy</li>\n<li>Post-op vaginal vault radiotherapy</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>II</strong></td>\n<td>\n<ul>\n<li>Surgery</li>\n<li>Post-op brachytherapy</li>\n<li>Post-op external beam radiotherapy</li>\n<li>Wertheim's hysterectomy</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>III</strong></td>\n<td>\n<ul>\n<li>Inoperable/ Cytoreduction</li>\n<li>Chemotherapy with Doxorubicin+Cisplatin+Paclitaxel</li>\n<li>Medroxyprogesterone&nbsp;adjuvant</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>IV</strong></td>\n<td>\n<ul>\n<li>Inoperable/ Cytoreduction</li>\n<li>Palliative radiotherapy/chemo/ progesterone therapy</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*This pearl is in line with the FIGO 2010 guidelines. It will be updated according to the FIGO 2023 guidelines after an official treatment guideline is released.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5082",
      "difficulty": "medium"
    },
    {
      "text": "A woman with endometrial carcinoma is undergoing radiotherapy. Which of the following is true?",
      "choices": [
        {
          "id": 1,
          "text": "Intensity is inversely proportional to squared distance"
        },
        {
          "id": 2,
          "text": "Small blood vessels are most radioresistant"
        },
        {
          "id": 3,
          "text": "Rapidly proliferating cells are most radioresistant"
        },
        {
          "id": 4,
          "text": "Small bowel is most radioresistant"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>intensity</strong> of radiation is <strong>inversely proportional </strong>to<strong>&nbsp;the squared distance. </strong>This is known as the <strong>inverse square law</strong>&nbsp;in radiotherapy.</p>\n<p><strong>Chemoradiation</strong> is the mainstay of treatment of <strong>stage III and IV</strong> endometrial cancers. They are treated with brachytherapy followed by external radiation.<span class=\"Apple-converted-space\">&nbsp;</span><strong><span class=\"Apple-converted-space\">Brachytherapy</span></strong><span class=\"Apple-converted-space\">&nbsp;</span>is a form of radiation therapy in which the <strong>radiation source </strong>is placed<strong> close to </strong>the <strong>tumor</strong>.<span class=\"Apple-converted-space\">&nbsp;</span></p>\n<p><span class=\"Apple-converted-space\">Other options:&nbsp;</span></p>\n<p>Option B: <strong>Larger blood vessels</strong> are more <strong>radioresistant</strong> than microvasculature.</p>\n<p>Option C: <strong>Permanent non-dividing cells</strong> are more <strong>radioresistant</strong> than rapidly proliferating cells.</p>\n<p>Option D: <strong>Small intestinal epithelial cells</strong> (intestinal crypts), which divide rapidly with no differentiation are the <strong>most radiosensitive</strong>.</p><hr><h3>Related Pearl: Ca.Endometrium staging (Revised FIGO)</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/63d7bd1024964af5a59c406cbaa3fc47x1280x3298.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4a582a55999043d8a33c2034dd59de86x1280x882.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Management of endometrial cancer</h3><p>Surgery is done for staging of the cancer. The surgery done for this purpose is abdominal hysterectomy, bilateral salpingo-oophorectomy, omentectomy, and pelvic as well as para-aortic lymph node sampling.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Stage</strong></td>\n<td><strong>Treatment</strong></td>\n</tr>\n<tr>\n<td><strong>IA noninvasive&nbsp;</strong></td>\n<td>\n<ul>\n<li>Surgery alone</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>IA</strong></td>\n<td>\n<ul>\n<li>Surgery</li>\n<li>Post-op radiotherapy</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>IB</strong></td>\n<td>\n<ul>\n<li>Surgery</li>\n<li>Post-op pelvic radiotherapy 4000-5000 cGy</li>\n<li>Post-op vaginal vault radiotherapy</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>II</strong></td>\n<td>\n<ul>\n<li>Surgery</li>\n<li>Post-op brachytherapy</li>\n<li>Post-op external beam radiotherapy</li>\n<li>Wertheim's hysterectomy</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>III</strong></td>\n<td>\n<ul>\n<li>Inoperable/ Cytoreduction</li>\n<li>Chemotherapy with Doxorubicin+Cisplatin+Paclitaxel</li>\n<li>Medroxyprogesterone&nbsp;adjuvant</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>IV</strong></td>\n<td>\n<ul>\n<li>Inoperable/ Cytoreduction</li>\n<li>Palliative radiotherapy/chemo/ progesterone therapy</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*This pearl is in line with the FIGO 2010 guidelines. It will be updated according to the FIGO 2023 guidelines after an official treatment guideline is released.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3068",
      "difficulty": "medium"
    },
    {
      "text": "Which among the following is the mainstay of treatment in a patient diagnosed with Stage III endometrial cancer?",
      "choices": [
        {
          "id": 1,
          "text": "Surgery"
        },
        {
          "id": 2,
          "text": "Chemotherapy"
        },
        {
          "id": 3,
          "text": "External beam radiotherapy"
        },
        {
          "id": 4,
          "text": "Brachytherapy"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Chemotherapy</strong> is the mainstay of treatment in <strong>Stage III endometrial cancer</strong>.</p>\n<p>In order to stage carcinoma endometrium, total abdominal hysterectomy with bilateral salpingo-oophorectomy and lymphadenectomy is done (surgical staging). </p>\n<p>Thus the management, once staging is done, is mainly postoperative. Up to <strong>stage II</strong>, <strong>radiotherapy</strong> can be given. Stages <strong>III &amp; IV</strong> are managed by chemotherapy such as <strong>doxorubicin, cisplatin,</strong> and<strong> paclitaxel.</strong></p>\n<p>Note: <strong>Stage III</strong> is said to be inoperable but <strong>debulking surgery</strong> is sometimes attempted. However, the mainstay of treatment for stage III disease remains chemotherapy.</p><hr><h3>Related Pearl: Management of endometrial cancer</h3><p>Surgery is done for staging of the cancer. The surgery done for this purpose is abdominal hysterectomy, bilateral salpingo-oophorectomy, omentectomy, and pelvic as well as para-aortic lymph node sampling.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Stage</strong></td>\n<td><strong>Treatment</strong></td>\n</tr>\n<tr>\n<td><strong>IA noninvasive&nbsp;</strong></td>\n<td>\n<ul>\n<li>Surgery alone</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>IA</strong></td>\n<td>\n<ul>\n<li>Surgery</li>\n<li>Post-op radiotherapy</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>IB</strong></td>\n<td>\n<ul>\n<li>Surgery</li>\n<li>Post-op pelvic radiotherapy 4000-5000 cGy</li>\n<li>Post-op vaginal vault radiotherapy</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>II</strong></td>\n<td>\n<ul>\n<li>Surgery</li>\n<li>Post-op brachytherapy</li>\n<li>Post-op external beam radiotherapy</li>\n<li>Wertheim's hysterectomy</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>III</strong></td>\n<td>\n<ul>\n<li>Inoperable/ Cytoreduction</li>\n<li>Chemotherapy with Doxorubicin+Cisplatin+Paclitaxel</li>\n<li>Medroxyprogesterone&nbsp;adjuvant</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>IV</strong></td>\n<td>\n<ul>\n<li>Inoperable/ Cytoreduction</li>\n<li>Palliative radiotherapy/chemo/ progesterone therapy</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*This pearl is in line with the FIGO 2010 guidelines. It will be updated according to the FIGO 2023 guidelines after an official treatment guideline is released.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5083",
      "difficulty": "medium"
    }
  ]
}